Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart Failure

Journal of the American College of Cardiology

Volumn 48, Issue 6, 2006, Pages 1225-1227

  Bolger, Aidan P ^a   Bartlett, Frederick R ^b   Penston, Helen S ^b   O'Leary, Justin ^a   Pollock, Noel ^b   Kaprielian, Raffi ^b   Chapman, Callum M ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERRIC HYDROXIDE SUCROSE; FERRITIN; HEMOGLOBIN; LOOP DIURETIC AGENT; SPIRONOLACTONE; TRANSFERRIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EXERCISE TEST; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; ANEMIA; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; FEMALE; FERRIC COMPOUNDS; GASTROINTESTINAL DISEASES; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; PROSPECTIVE STUDIES; TRANSFERRIN; WALKING;

EID: 33748438999     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.07.015     Document Type: Article

References (9)

1. Felker G.M., Adams Jr. K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
2. Mozaffarian D., Nye R., and Levy W.C. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 41 (2003) 1933-1939
3. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37 (2001) 1775-1780
4. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., and Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
5. Silverberg D.S., Iaina A., Peer G., et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 27 (1996) 234-238
6. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
7. Kalra P.R., Bolger A.P., Francis D.P., et al. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 91 (2003) 888-891
8. Macdougall I.C., and Roche A. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. Am J Kidney Dis 46 (2005) 283-289
9. Van Wyck D.B., Cavallo G., Spinowitz B.S., et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis 36 (2000) 88-97